Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.
about
In silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2)Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.The effect of statins on cancer cells--review.Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin.
P2860
Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evaluation of the pharmacokine ...... rosuvastatin and pitavastatin.
@en
type
label
Evaluation of the pharmacokine ...... rosuvastatin and pitavastatin.
@en
prefLabel
Evaluation of the pharmacokine ...... rosuvastatin and pitavastatin.
@en
P2860
P1476
Evaluation of the pharmacokine ...... rosuvastatin and pitavastatin.
@en
P2093
Brian Tomlinson
P2860
P356
10.1517/17425255.2014.851667
P407
P577
2013-10-25T00:00:00Z